Literature DB >> 9753555

Folding and association of beta-Galactosidase.

A Nichtl1, J Buchner, R Jaenicke, R Rudolph, T Scheibel.   

Abstract

beta-D-Galactosidase from Escherichia coli is one of the largest tetrameric enzymes known at present. Although its physiological importance, the regulation of its synthesis, its enzymatic properties and its structure are well established, little is known about the stability and the folding pathway of this enzyme. Here we show that the overall folding mechanism of chemically denatured beta-galactosidase consists of three stages: (i) formation of elements of secondary structure; (ii) collapse to subdomains and structured monomers; (iii) association to the native quaternary structure via dimeric intermediates. The first rate-limiting step is the association of structured monomers to form dimers in a bi-molecular reaction, with a rate constant of 4.3x10(3) M-1 s-1 at 20 degreesC. The second rate-limiting uni-molecular folding step leads to dimers which are competent for further association, with a rate constant of 0.5x10(-3) s-1 at 20 degreesC. Tetramers form from these dimers in a fast reaction. By determining a similar mechanism for alpha-complementation of beta-galactosidase fragments it could be confirmed that beta-galactosidase follows a consecutive bi-uni-molecular mechanism of folding and association. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753555     DOI: 10.1006/jmbi.1998.2075

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  High resolution refinement of beta-galactosidase in a new crystal form reveals multiple metal-binding sites and provides a structural basis for alpha-complementation.

Authors:  D H Juers; R H Jacobson; D Wigley; X J Zhang; R E Huber; D E Tronrud; B W Matthews
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

2.  The substrate binding domain of DnaK facilitates slow protein refolding.

Authors:  Naoki Tanaka; Shota Nakao; Hiromasa Wadai; Shoichi Ikeda; Jean Chatellier; Shigeru Kunugi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

3.  A perspective on mechanisms of protein tetramer formation.

Authors:  Evan T Powers; David L Powers
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

4.  The DnaK chaperone is necessary for alpha-complementation of beta-galactosidase in Escherichia coli.

Authors:  Nicolas Lopes Ferreira; Jean-Hervé Alix
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

5.  Protein engineering of a cold-active beta-galactosidase from Arthrobacter sp. SB to increase lactose hydrolysis reveals new sites affecting low temperature activity.

Authors:  James A Coker; Jean E Brenchley
Journal:  Extremophiles       Date:  2006-05-31       Impact factor: 2.395

6.  Effect of human neuronal tau on denaturation and reactivation of rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Y H Chen; R Q He; Y Liu; Y Liu; Z G Xue
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

7.  Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease.

Authors:  R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Biochemistry       Date:  2005-12-20       Impact factor: 3.162

8.  Monomer topology defines folding speed of heptamer.

Authors:  Neil Bascos; Jesse Guidry; Pernilla Wittung-Stafshede
Journal:  Protein Sci       Date:  2004-04-09       Impact factor: 6.725

9.  Biochemical characterization of a beta-galactosidase with a low temperature optimum obtained from an Antarctic arthrobacter isolate.

Authors:  James A Coker; Peter P Sheridan; Jennifer Loveland-Curtze; Kevin R Gutshall; Ann J Auman; Jean E Brenchley
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

10.  Expanding the utility of beta-galactosidase complementation: piece by piece.

Authors:  Ann-Marie Broome; Nihir Bhavsar; Gopalakrishnan Ramamurthy; Gail Newton; James P Basilion
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.